These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3147175)

  • 21. The effect of stress on glycemic control in patients with type II diabetes during glyburide and glipizide therapy.
    Jaber LA; Lewis NJ; Slaughter RL; Neale AV
    J Clin Pharmacol; 1993 Mar; 33(3):239-45. PubMed ID: 8463437
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diurnal pattern of plasma insulin and blood glucose during glibenclamide and glipizide therapy in elderly diabetics.
    Groop L; Harno K
    Acta Endocrinol Suppl (Copenh); 1980; 239():44-52. PubMed ID: 6776763
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical comparison between glibornuride (Glutril) and glibenclamide in maturity-onset diabetes: a controlled double-blind trial.
    Mogensen EF; Worm J; Mikkelsen BO
    Curr Ther Res Clin Exp; 1976 Jun; 19(6):559-64. PubMed ID: 132338
    [No Abstract]   [Full Text] [Related]  

  • 24. Oral sulfonylureas for the treatment of type II diabetes: an update.
    Shank WA; Morrison AD
    South Med J; 1986 Mar; 79(3):337-43. PubMed ID: 3082015
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Benefits and risks with glyburide and glipizide in elderly NIDDM patients.
    Brodows RG
    Diabetes Care; 1992 Jan; 15(1):75-80. PubMed ID: 1737544
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The risk of overall mortality in patients with Type 2 diabetes receiving different combinations of sulfonylureas and metformin: a retrospective analysis.
    Pantalone KM; Kattan MW; Yu C; Wells BJ; Arrigain S; Nutter B; Jain A; Atreja A; Zimmerman RS
    Diabet Med; 2012 Aug; 29(8):1029-35. PubMed ID: 22248043
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A clinical study of a new sulfonylures hypoglycemic agent: glipizide (glibenese)(author's transl)].
    Cochet B; Balant L; Rilliet B; Zahnd G
    Schweiz Rundsch Med Prax; 1975 May; 64(18):562-8. PubMed ID: 1161734
    [No Abstract]   [Full Text] [Related]  

  • 28. [Glipizide: a 2d generation sulfonamide and new antidiabetic].
    Deuil R
    Nouv Presse Med; 1975 Feb; 4(7):500-1. PubMed ID: 1093131
    [No Abstract]   [Full Text] [Related]  

  • 29. Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group.
    DeFronzo RA; Goodman AM
    N Engl J Med; 1995 Aug; 333(9):541-9. PubMed ID: 7623902
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.
    Lancet; 1998 Sep; 352(9131):837-53. PubMed ID: 9742976
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bed time NPH-insulin plus combined sulfonylurea-biguanide oral therapy for treating refractory non insulin dependent diabetic patients.
    di Cianni G; Benzi L; Ciccarone AM; Cecchetti P; Navalesi R
    Diabete Metab; 1992; 18(6):468-9. PubMed ID: 1297606
    [No Abstract]   [Full Text] [Related]  

  • 32. The second generation oral sulfonylureas: glyburide and glipizide.
    Kuhn T
    Am Pharm; 1988 Oct; NS28(10):55-61. PubMed ID: 3143256
    [No Abstract]   [Full Text] [Related]  

  • 33. The risk of overall mortality in patients with type 2 diabetes receiving glipizide, glyburide, or glimepiride monotherapy: a retrospective analysis.
    Pantalone KM; Kattan MW; Yu C; Wells BJ; Arrigain S; Jain A; Atreja A; Zimmerman RS
    Diabetes Care; 2010 Jun; 33(6):1224-9. PubMed ID: 20215447
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sulfonylurea-induced decrease of muscle capillary basement membrane thickness in diabetes.
    Camerini-Davalos RA; Velasco CA; Glasser M; Bloodworth JM
    Diabetes Res Clin Pract; 1988 Jul; 5(2):113-23. PubMed ID: 3046878
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of glipizide and food intake on the blood levels of glucose and insulin in diabetic patients.
    Sartor G; Scherstén B; Melander A
    Acta Med Scand; 1978; 203(3):211-4. PubMed ID: 345754
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of bed time intermediate acting insulin in NIDDM subjects refractory to a combination of sulphonylureas and biguanides.
    Seshiah V; Shanker R; Madhavan R; Venkataraman S; Sundaram A; Seshasaianam C; Sankaran JR
    J Assoc Physicians India; 1992 Oct; 40(10):666-8. PubMed ID: 1307353
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improvements in glycemic control in type 2 diabetes patients switched from sulfonylurea coadministered with metformin to glyburide-metformin tablets.
    Duckworth W; Marcelli M; Padden M; Kellick K; Duhancik T; Wilhardt M; Colgan K; Romie A
    J Manag Care Pharm; 2003; 9(3):256-62. PubMed ID: 14613469
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical testing of a sulphonylurea derivative, glibornuride].
    Zöllner N; Dörfler H; Wolfram G
    Dtsch Med Wochenschr; 1972 Jul; 97(29):1083-8. PubMed ID: 4625427
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical pharmacology of glipizide.
    Melander A; Wåhlin-Boll E
    Am J Med; 1983 Nov; 75(5B):41-5. PubMed ID: 6424440
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative efficacy and potency of long-term therapy with glipizide or glyburide in patients with type 2 diabetes mellitus.
    Kitabchi AE; Kaminska E; Fisher JN; Sherman A; Pitts K; Bush A; Bryer-Ash M
    Am J Med Sci; 2000 Mar; 319(3):143-8. PubMed ID: 10746824
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.